Reconnect Labs is a Swiss, clinical stage pharmaceutical company developing Regenerative Therapeutics™ for mental health at the forefront of neuroscience and precision psychopharmacology. Led by neuroscientists from the University of Zurich Psychiatric University Clinic (PUKZH), Reconnect translates 30 years of in-human research and clinical practice to solve for the safety, efficacy and commercialization challenges of generation 1 psychoplastogens, Reconnect originated a portfolio of psychoactive formulations for affective and neurodegenerative disorders, chronic pain and insomnia.
Location: Switzerland, Zurich, Winterthur
Employees: 1-10
Founded date: 2021
Investors 1
| Date | Name | Website |
| - | Esperante | esperante.... |
Mentions in press and media 6
| Date | Title | Description |
| 22.10.2025 | Promising results in oncology research | iOnctura, a clinical-stage precision oncology company focused on neglected and hard-to-treat cancers, conducted a Phase Ib study, AION-02 (NCT05586516), on its investigating oral autotaxin (ATX) inhibitor, cambritaxestat (IOA-289), in pati... |
| 20.08.2025 | Reconnect Labs emerges from stealth mode fully funded | For decades, innovation in psychiatry has lagged behind other fields of medicine. Traditional psychiatric drug development has predominantly focused on single molecular targets and incremental symptom relief, often neglecting the broader p... |
| 08.11.2024 | Bio-Europe: Switzerland's Biotech Showcase in Stockholm | The heart of Europe beats strong in Stockholm this November. Bio-Europe, the continent's premier partnering event for the life sciences, is back for its 30th edition. This year, it promises to be a melting pot of innovation, collaboration, ... |
| 05.11.2024 | Bio Europe in Stockholm hosts 33 Swiss companies | Currently in its 30-year-edition, BIO-Europe remains Europe's leading partnering event, for the life sciences ecosystem, providing an exceptional opportunity to explore the latest trends learn and connect with potential partners. The past ... |
| 27.03.2023 | Here are the 15 hottest startups in the psychedelics industry, according to top investors | From left: Sherry Rais, a cofounder and the CEO of Enthea; Mark Rus, the CEO of Delix Therapeutics; Jackie von Salm, a cofounder and the CSO of Psilera; Jimmy Qian, a cofounder and the president of Osmind. Sherry Rais/Enthea; Mark Rus/Delix... |
| 16.03.2023 | Swiss startups prepare to visit the US East Coast |